Glucagon (1 – 37), porcine; Oxyntomodulin, porcine CAS NO.62340-29-8

Glucagon (1 – 37), porcine; Oxyntomodulin, porcine CAS NO.62340-29-8

Glucagon (1 – 37), porcine; Oxyntomodulin, porcine CAS NO.62340-29-8

Glucagon (1 – 37), porcine; Oxyntomodulin, porcine CAS NO.62340-29-8

Glucagon (1-37), porcine; Oxyntomodulin, porcine is a dual-product offering featuring two distinct porcine-derived peptides: full-length glucagon (37 amino acids) and oxyntomodulin. Both peptides are derived from the same precursor (proglucagon) but exhibit different biological activities and receptor specificities. Glucagon (1-37) functions primarily as a hyperglycemic hormone targeting glucagon receptors, while oxyntomodulin acts on both glucagon-like peptide-1 (GLP-1) and glucagon receptors, influencing glucose metabolism and appetite regulation. Supplied as high-purity lyophilized powders with HPLC-verified quality and comprehensive analytical documentation, these peptides provide researchers with valuable tools for comparative metabolic studies, receptor pharmacology, and gastrointestinal hormone research in porcine models.


TECHNICAL SPECIFICATIONS


Item
Specification
Product Name
Glucagon (1 – 37), porcine; Oxyntomodulin, porcine
CAS NO.
62340-29-8
Appearance
White to off-white lyophilized powder
Molecular Formula
C192H295N59O60S
Molecular Weight
 4421.92g/mol 
Purity (RP-HPLC)
≥ 95.0%
Solubility

Soluble in water, dilute acetic acid, and alkaline buffers (pH 8-10); gentle solubilization may be necessary.

Endotoxin< 1.0 EU/mg
Biological Activity

Glucagon (1-37), porcine: Glucagon promotes glycogenolysis in the liver and raises blood glucose levels. 

Oxyntomodulin, porcine: A hormone secreted by L cells in the intestine, possessing multiple metabolic regulatory functions, including inhibiting gastric acid secretion, reducing food intake, and stimulating insulin release.

Storage Conditions
Store at -20°C or below, protected from light and moisture. After reconstitution, aliquot and store at -20°C
Stock Location
Stock in USA
MOQ
1g


1.MECHANISM OF ACTION

Glucagon (1-37), porcine binds to glucagon receptors (GCGR) in the liver, activating G-protein coupled signaling that increases intracellular cAMP levels. This leads to activation of protein kinase A (PKA), resulting in glycogenolysis, gluconeogenesis, and increased hepatic glucose output, ultimately raising blood glucose levels.

Oxyntomodulin, porcine exhibits dual receptor activity: it binds to both GLP-1 receptors (GLP-1R) and glucagon receptors (GCGR) with varying affinities. Activation of GLP-1R enhances insulin secretion, inhibits glucagon release, and delays gastric emptying, while interaction with GCGR may contribute to its metabolic effects. The combined receptor activation results in reduced food intake, increased energy expenditure, and improved glucose homeostasis.


2.PRODUCT INDICATIONS

Comparative Metabolic Studies: Investigation of differential effects between glucagon and oxyntomodulin on glucose metabolism and energy balance

Receptor Pharmacology: Evaluation of binding affinities and signaling pathways for GCGR and GLP-1R using porcine-specific peptides

Gastrointestinal Hormone Research: Study of proglucagon-derived peptides in appetite regulation and gut hormone interactions

Diabetes and Obesity Research: Exploration of therapeutic potential in metabolic disorders using porcine models
Species-Specific Studies: Research requiring porcine-derived peptides for physiological relevance in pig models
Preclinical Development: Assessment of metabolic effects and safety profiles in porcine systems


3.CLINICAL EFFICACY OF PRODUCT

High Purity: Both peptides ≥95% by RP-HPLC with mass spectrometry confirmation of sequence and molecular weight

Species Specificity: Porcine-derived sequences optimized for porcine receptor studies and cross-species comparison

Biological Activity Validation: Demonstrated receptor binding and functional activity in validated assay systems

Research Reproducibility: Consistent performance in metabolic assays, receptor binding studies, and animal models

Quality Documentation: Certificate of Analysis provided for each peptide with purity, mass spec, and analytical data

Technical Support: Access to species-specific application guidance and experimental design consultation


    4.DELIVERY & SHIPPING

    We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
    Professional and Secure Packaging
    Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
    We can also customize packaging according to customer needs.
    Shipping Methods 
    Main Method: International Air Freight

    We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.

Premium API Oxandrolone Ucinky Manufacturing
May 25, 26
Premium API Oxandrolone Ucinky Manufacturing
Premium API Oxandrolone Ucinky Manufacturing Leading global supplier of high-purity chemical raw materials for pharmaceutical grade Oxandrolone Ucinky, combining precision engineering with industrial scale. 5000 kg Annual Output 120 Countries Served 5 Days Sample Lead Time 99.7 On-Time Delivery Industrial Precision Pure Chemical Synthesis Engineering the future of pharmaceutical intermediates with unmatched stability. Our facility stands as a global leader in the oxandrolone ucinky sector, utilizing CRYOGENIC CRYSTALLIZATION and advanced chromatography to ensure an assay purity exceeding 99.8. We integrate a fully automated closed-loop system that eliminates human error and contamination.
Clinical Benefits and Applications of Oxandrolone Therapy
May 22, 26
Clinical Benefits and Applications of Oxandrolone Therapy
Oxandrolone therapy represents a sophisticated intersection of endocrine science and regenerative medicine, primarily utilized to address muscle wasting and metabolic dysfunction. In the global pharmaceutical landscape, this specific approach to androgen therapy is valued for its unique ability to promote protein synthesis while exhibiting a lower androgenic profile compared to traditional steroids, making it a critical tool for patients recovering from severe trauma or chronic illness. From a clinical perspective, understanding the nuances of oxandrolone therapy is essential for optimizing patient outcomes in weight gain and tissue repair.
Clinical Benefits and Production of Oxandrolone Steroid
May 20, 26
Clinical Benefits and Production of Oxandrolone Steroid
The global pharmaceutical landscape has seen a significant rise in the demand for highly specialized anabolic agents, among which the oxandrolone steroid stands out due to its unique chemical profile and therapeutic versatility. As a modified version of dihydrotestosterone, this compound provides a potent means of addressing muscle wasting and metabolic deficits, making it a critical asset in both clinical rehabilitation and advanced physiological research. Understanding the nuances of this synthetic compound is essential for healthcare providers and researchers alike, as it balances efficacy with a relatively lower androgenic profile compared to other steroids.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.